Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Haematologica|April 8, 2014
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitorsSung-Hyun Kim, Hari Menon, Saengsuree Jootar, et al.
Leukemia Research|October 21, 2021
Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patientsHyunkyung Park, Inho Kim, Hyeong-Joon Kim, et al.
Annals of Hematology|May 22, 2026
Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemiaSeok Lee, Hyeoung-Joon Kim, June-Won Cheong, et al.
American Journal of Hematology|February 27, 2013
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinibSung-Eun Lee, Soo Young Choi, Ju-Hee Bang, et al.
American Journal of Hematology|August 1, 2015
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemiaSung-Nam Lim, Young-Don Joo, Kyoo-Hyung Lee, et al.
Leukemia & Lymphoma|April 6, 2011
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemiaSang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, et al.
Blood Research|June 9, 2022
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in KoreaSeo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, et al.
Cancer Medicine|March 27, 2018
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKoreaJunghoon Shin, Youngil Koh, Seo Hyun Yoon, et al.
The Korean Journal of Internal Medicine|July 11, 2022
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemiaYoung Hoon Park, Dae-Young Kim, Yeung-Chul Mun, et al.
Blood|June 13, 2015
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaDae-Young Kim, Young-Don Joo, Sung-Nam Lim, et al.
Pageof 12